AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TACROLIMUS
58 registrations across 10 African markets— 44 active
Markets with TACROLIMUS
🇿🇦South Africa
20 registrations
19 active
🇹🇳Tunisia
10 registrations
0 active
🇹🇿Tanzania
8 registrations
8 active
🇲🇦Morocco
4 registrations
4 active
🇺🇬Uganda
4 registrations
4 active
🇲🇼Malawi
3 registrations
0 active
🇿🇲Zambia
3 registrations
3 active
🇳🇬Nigeria
2 registrations
2 active
🇿🇼Zimbabwe
2 registrations
2 active
🇷🇼Rwanda
2 registrations
2 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TACROCORD 5 CAPSULES Hard Gelatin Capsule | 🇿🇲Zambia | PRISMA PHARMA FZE | active | May 2031 |
| Eczemus 0.03% Ointment Ointment | 🇷🇼Rwanda | concord biotech ltd | active | May 2031 |
| Talimus 0.03% Ointment Ointment for Topical Use | 🇿🇲Zambia | Ajanta Pharma Limited | active | Jul 2030 |
| Talimus 0.1% Ointment Ointment for Topical Use | 🇿🇲Zambia | Ajanta Pharma Limited | active | Jul 2030 |
| VINGRAF 1 capsules | 🇷🇼Rwanda | M/s RIVPRA FORMULATIONS PVT | active | Aug 2029 |
| LIMMUPRES 5 | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Mar 2029 |
| LIMMUPRES 0,5 | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Mar 2029 |
| LIMMUPRES 0,5 | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Mar 2029 |
| TACROZ FORTE GEL | 🇿🇼Zimbabwe | GLENMARK PHARMACEUTICAL LIMITED | active | Feb 2029 |
| TACROZ FORTE GEL | 🇿🇼Zimbabwe | GLENMARK PHARMACEUTICAL LIMITED | active | Feb 2029 |
| GRAFTAC 1 PROLONGED RELEASE | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2029 |
| GRAFTAC 1,5 PROLONGED RELEASE | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2029 |
| GRAFTAC 0,5 PROLONGED RELEASE | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 2029 |
| Tacrolimus Sandoz 1 mg Capsule Capsule | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2026 |
| Tacrolimus Sandoz 5 mg Capsule Capsule | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2026 |
| PROGRAF 0,5 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 2026 |
| MUNOGRAF 0,5 | 🇿🇦South Africa | Accord Healthcare (Pty) Ltd | suspended | Jun 2025 |
| TALIMUS 0.1%W/W OINTMENT OINTMENT | 🇲🇼Malawi | — | expired | Mar 2025 |
| TACROLIMUS MEDIS Gélule / 0.5 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2023 |
| PROTOPIC Pommade dermique / 0.1 % | 🇹🇳Tunisia | LEO PHARMA A/S | expired | Aug 2019 |
| PROTOPIC Pommade dermique / 0.03 % | 🇹🇳Tunisia | LEO PHARMA A/S | expired | Aug 2019 |
| TACROVATE 0.03%W/W OINTMENT OINTMENT | 🇲🇼Malawi | — | expired | Jun 2019 |
| TACROVATE-FORTE 0.1%W/W OINTMENT OINTMENT | 🇲🇼Malawi | — | expired | Jun 2019 |
| ADVAGRAF LP Gélule à libération prolongée / 1 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2017 |
| ADVAGRAF LP Gélule à libération prolongée / 5 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2017 |
| ADVAGRAF LP Gélule à libération prolongée / 0.5 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2017 |
| TACROLIMUS MEDIS Gélule / 1 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | May 2014 |
| TACROLIMUS MEDIS Gélule / 5 mg | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | May 2014 |
| PROGRAF Gélule / 5 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Aug 2001 |
| PROGRAF Gélule / 1 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Aug 2001 |
| TACOGRAF 1 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| TACOGRAF 5 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ADVAGRAF 5 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| PROTOPIC 0,03 % OINTMENT | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| PROTOPIC 0,1 % OINTMENT | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| PANGRAF 5 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| PANGRAF 1 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ADVAGRAF 0,5 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| PROGRAF CONCENTRATE FOR INFUSION 5 mg/ml | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| PANGRAF 0,5 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| TACOGRAF 0,5 mg | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ADVAGRAF 1 mg | 🇿🇦South Africa | Astellas Pharma (Pty) Ltd | active | Jan 1900 |
| PROGRAF GELULE | 🇲🇦Morocco | — | active | — |
| Pangraf 0.5 Capsules | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
| PROGRAF GELULE | 🇲🇦Morocco | — | active | — |
| Pangraf 1.0 Capsules | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
| TACROLIMUS TOPICAL
EXTERNAL
OINTMENTS | 🇺🇬Uganda | AJANTA PHARMA LTD | active | — |
| PANGRAF 5 Capsules | 🇹🇿Tanzania | PANACEA BIOTEC PHARMA LIMITED | active | — |
| Tacroz Forte Ointment | 🇹🇿Tanzania | Glenmark Pharmaceuticals Limited | active | — |
| TACROLIMUS TOPICAL
EXTERNAL
OINTMENTS | 🇺🇬Uganda | AJANTA PHARMA LTD | active | — |
Showing 50 of 58 registrations. Sign up free to search and export all.
TACROLIMUS in Africa — Regulatory Overview
TACROLIMUS is registered across 10 African markets with 58 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Tanzania, Morocco and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 58 registrations, 44 (76%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.